NCT00067613

Brief Summary

This study tested whether Neonatal Intensive Care Unit (NICU) teams trained in benchmarking -- comparing care practices between different NICUs to see which practices prevent bronchopulmonary dysplasia (BPD) -- and quality improvement would change practices and improve rates of survival without BPD in inborn neonates with birth weights of \<1250 grams. Benchmarking is a method involving detailed comparisons of processes between similar organizations. For this study, three NRN centers with the lowest rates of BPD have been identified as Benchmark centers. During a 6-month pre-intervention period, details of care practices and management style at these centers were carefully assessed. Based on practices at these Benchmarking sites, we developed a quality improvement program. For this study, 14 other NRN sites were randomized to either implement the benchmarking intervention (intervention sites) or continue with their usual care practices (control sites). After the 1-year intervention period, we compared changes in the rate of survival without BPD at 36 weeks corrected age between the intervention and control sites.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,095

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2001

Longer than P75 for not_applicable

Geographic Reach
1 country

17 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2001

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

August 25, 2003

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 26, 2003

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2004

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2004

Completed
Last Updated

June 8, 2015

Status Verified

June 1, 2015

Enrollment Period

3.2 years

First QC Date

August 25, 2003

Last Update Submit

June 3, 2015

Conditions

Keywords

NICHD Neonatal Research NetworkExtremely Low Birth Weight (ELBW)Very Low Birth Weight (VLBW)PrematurityMechanical ventilationBenchmarkingChronic Lung Disease (CLD)

Outcome Measures

Primary Outcomes (1)

  • Survival without BPD

    36 weeks of life

Secondary Outcomes (1)

  • Bronchopulmonary Dysplasia

    36 weeks of life

Study Arms (2)

Intervention

ACTIVE COMPARATOR

Clinical sites randomized to intervention will receive training in the benchmarking BPD management methods identified at the Benchmark sites.

Other: Benchmarking Management Practices

Control

PLACEBO COMPARATOR

Clinical sites randomized to Control will continue with their normal management practices for BPD.

Other: Standard Management Practices

Interventions

The Benchmarking intervention included: 1. Data feedback: Using existing data from the NRN Generic Database and Key Care Practices Survey at their NICU to collect data on the perceptions of care. 2. Training in Continuous Quality Improvement (CQI) Techniques 3. Review of best existing evidence 4. Site visits to the Centers with the Lowest Rates of BPD 5. Selection of Practices to change: Each site team selected practices for modification at their own center

Intervention

Centers assigned to the control group continued to receive routine information on their own center's outcomes, and all information routinely supplied within the NRN. Control centers did not participate in organized discussions of the interventions applied within the Benchmarking centers. At the completion of the study, Control Centers were offered a workshop on the Benchmarking techniques.

Control

Eligibility Criteria

AgeUp to 36 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Infants 501-1,249g birthweight
  • Registered in a participating site

You may not qualify if:

  • Diagnosed with a syndrome as defined by the Neonatal Research Network's Generic Database Study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (17)

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

Stanford University

Palo Alto, California, 94304, United States

Location

University of California at San Diego

San Diego, California, 92103-8774, United States

Location

Yale University

New Haven, Connecticut, 06504, United States

Location

University of Miami

Miami, Florida, 33136, United States

Location

Emory University

Atlanta, Georgia, 30303, United States

Location

Indiana University

Indianapolis, Indiana, 46202, United States

Location

Wayne State University

Detroit, Michigan, 48201, United States

Location

University of Rochester

Rochester, New York, 14642, United States

Location

Wake Forest University

Charlotte, North Carolina, 27157, United States

Location

RTI International

Durham, North Carolina, 27705, United States

Location

Duke University

Durham, North Carolina, 27710, United States

Location

Cincinnati Children's Medical Center

Cincinnati, Ohio, 45267, United States

Location

Case Western Reserve University, Rainbow Babies and Children's Hospital

Cleveland, Ohio, 44106, United States

Location

Brown University, Women & Infants Hospital of Rhode Island

Providence, Rhode Island, 02905, United States

Location

University of Texas Southwestern Medical Center at Dallas

Dallas, Texas, 75235, United States

Location

University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

Related Publications (6)

  • Bhandari V, Finer NN, Ehrenkranz RA, Saha S, Das A, Walsh MC, Engle WA, VanMeurs KP; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Synchronized nasal intermittent positive-pressure ventilation and neonatal outcomes. Pediatrics. 2009 Aug;124(2):517-26. doi: 10.1542/peds.2008-1302. Epub 2009 Jul 27.

  • Laptook AR, Salhab W, Allen J, Saha S, Walsh M. Pulse oximetry in very low birth weight infants: can oxygen saturation be maintained in the desired range? J Perinatol. 2006 Jun;26(6):337-41. doi: 10.1038/sj.jp.7211500.

  • Shankaran S, Langer JC, Kazzi SN, Laptook AR, Walsh M; National Institute of Child Health and Human Development Neonatal Research Network. Cumulative index of exposure to hypocarbia and hyperoxia as risk factors for periventricular leukomalacia in low birth weight infants. Pediatrics. 2006 Oct;118(4):1654-9. doi: 10.1542/peds.2005-2463.

  • Walsh M, Laptook A, Kazzi SN, Engle WA, Yao Q, Rasmussen M, Buchter S, Heldt G, Rhine W, Higgins R, Poole K; National Institute of Child Health and Human Development Neonatal Research Network. A cluster-randomized trial of benchmarking and multimodal quality improvement to improve rates of survival free of bronchopulmonary dysplasia for infants with birth weights of less than 1250 grams. Pediatrics. 2007 May;119(5):876-90. doi: 10.1542/peds.2006-2656.

  • Walsh M, Engle W, Laptook A, Kazzi SN, Buchter S, Rasmussen M, Yao Q; National Institute of Child Health and Human Development Neonatal Research Network. Oxygen delivery through nasal cannulae to preterm infants: can practice be improved? Pediatrics. 2005 Oct;116(4):857-61. doi: 10.1542/peds.2004-2411.

  • Wilson-Costello D, Walsh MC, Langer JC, Guillet R, Laptook AR, Stoll BJ, Shankaran S, Finer NN, Van Meurs KP, Engle WA, Das A; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants. Pediatrics. 2009 Mar;123(3):e430-7. doi: 10.1542/peds.2008-1928. Epub 2009 Feb 9.

Related Links

MeSH Terms

Conditions

Premature BirthBronchopulmonary Dysplasia

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesVentilator-Induced Lung InjuryLung InjuryLung DiseasesRespiratory Tract DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Michele C. Walsh, MD

    Case Western Reserve University, Rainbow Babies & Children's Hospital

    STUDY DIRECTOR
  • William Oh, MD

    Brown University, Women & Infants Hospital of Rhode Island

    PRINCIPAL INVESTIGATOR
  • Waldemar A. Carlo, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR
  • Shahnaz Duara, MD

    University of Miami

    PRINCIPAL INVESTIGATOR
  • Barbara J. Stoll, MD

    Emory University

    PRINCIPAL INVESTIGATOR
  • James A. Lemons, MD

    Indiana University

    PRINCIPAL INVESTIGATOR
  • David K. Stevenson, MD

    Stanford University

    PRINCIPAL INVESTIGATOR
  • Neil N. Finer, MD

    University of California, San Diego

    PRINCIPAL INVESTIGATOR
  • Abbot R. Laptook, MD

    University of Texas Southwestern Medical Center

    PRINCIPAL INVESTIGATOR
  • Seetha Shankaran, MD

    Wayne State University

    PRINCIPAL INVESTIGATOR
  • Edward F. Donovan, MD

    Children's Hospital Medical Center, Cincinnati

    PRINCIPAL INVESTIGATOR
  • Ronald N. Goldberg, MD

    Duke University

    PRINCIPAL INVESTIGATOR
  • Dale L. Phelps, MD

    University of Rochester

    PRINCIPAL INVESTIGATOR
  • Jon E. Tyson, MD MPH

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR
  • T. Michael O'Shea, MD MPH

    Wake Forest University

    PRINCIPAL INVESTIGATOR
  • Richard A. Ehrenkranz, MD

    Yale University

    PRINCIPAL INVESTIGATOR
  • W. Kenneth Poole, PhD

    RTI International

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
NETWORK

Study Record Dates

First Submitted

August 25, 2003

First Posted

August 26, 2003

Study Start

March 1, 2001

Primary Completion

May 1, 2004

Study Completion

May 1, 2004

Last Updated

June 8, 2015

Record last verified: 2015-06

Locations